Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$28.51M
↑ 170% above average
Average (9y)
$-40.79M
Historical baseline
Range
High:$28.51M
Low:$-77.53M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $28.51M | +267.9% |
| 2023 | $-16.98M | +68.5% |
| 2022 | $-53.87M | -377.3% |
| 2021 | $-11.29M | +59.2% |
| 2020 | $-27.68M | +58.0% |
| 2019 | $-65.88M | +5.7% |
| 2018 | $-69.89M | +9.9% |
| 2017 | $-77.53M | -23.0% |
| 2016 | $-63.03M | -25.3% |
| 2015 | $-50.30M | - |